Polymorphism and pseudopolymorphism: Influencing the dissolution properties of the guanine derivative acyclovir

被引:43
作者
Kristl, A
Srcic, S
Vrecer, F
Sustar, B
Vojnovic, D
机构
[1] KRKA PO,R&D DIV,NOVO MESTO,SLOVENIA
[2] UNIV TRIESTE,DEPT PHARMACEUT SCI,TRIESTE,ITALY
关键词
polymorphic solvate; pseudopolymorphic solvate; acyclovir; anhydrous acyclovir; dissolution behavior; solid-solid transformation;
D O I
10.1016/0378-5173(96)04601-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this work we established that acyclovir exists in hydrated form and that the ratio between acyclovir and water molecules in the crystal structure is 3:2. The anhydrous crystalline form of acyclovir was also prepared, Both crystalline forms were examined by means of thermal analyses, X-ray powder diffraction, infrared spectroscopy, solubility and dissolution rate studies. The differences in almost all tested parameters between the acyclovir hydrated and anhydrous forms were observed. They were explained by different crystal forms of the substances examined. It was found, that besides hydrate, two anhydrous forms of acyclovir are present: the unstable one, obtained at a drying temperature below 150 degrees C (which converts to the hydrate almost immediately in the atmosphere), and the stable one, obtained at drying temperatures above 150 degrees C (which shows, on heating to 172 degrees C, the solid-solid transition). It was thus postulated that acyclovir can exist as a pseudopolymorphic and polymorphic solvate.
引用
收藏
页码:231 / 235
页数:5
相关论文
共 9 条
[1]   STRUCTURE AND CONFORMATION OF THE POTENT ANTI-HERPES AGENT 9-(2-HYDROXYETHOXYMETHYL)GUANINE (ACYCLOGUANOSINE) [J].
BIRNBAUM, GI ;
CYGLER, M ;
KUSMIEREK, JT ;
SHUGAR, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 103 (03) :968-974
[2]  
BRYN SR, 1982, SOLID STATE CHEM DRU, P6
[3]  
FUNG HL, 1974, CHEM PHARM BULL, V22, P454
[4]   LIPOPHILICITY OF GUANINE DERIVATIVES [J].
KRISTL, A ;
MRHAR, A ;
KOZJEK, F ;
KOBE, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 57 (03) :229-234
[5]  
MATSUMOTO H, 1988, CHEM PHARM BULL, V36, P1153
[6]   DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS [J].
SHEFTER, E ;
HIGUCHI, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (08) :781-&
[7]  
STIMAC A, 1990, SYNTHESIS-STUTTGART, P461
[8]  
WELLS JI, 1988, PHARM PREFORMULATION, P80
[9]  
YALKOWSKY SH, 1981, TECHNIQUES SOLUBILIZ, P160